Impact of Diabetes Duration on Efficacy and Safety of a Basal-Plus Regimen of Insulin Glargine Plus Once Daily Insulin Glulisine: A Pooled Analysis From 4 Clinical Trials

被引：0
|
作者：
Owens, David R.
Del Prato, Stefano
Lin, Jay
Wang, Edward
Lankisch, Mark
机构：
来源：
DIABETES | 2012年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2378-PO
引用
收藏
页码：A599 / A599
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of once-daily insulin degludec/insulin aspart compared with once-daily insulin glargine in participants with Type 2 diabetes: a randomized, treat-to-target study
    Kumar, S.
    Jang, H. C.
    Demirag, N. G.
    Skjoth, T. V.
    Endahl, L.
    Bode, B.
    [J]. DIABETIC MEDICINE, 2017, 34 (02) : 180 - 188
  • [42] Patient Reported Outcomes Using Twice-Daily Insulin Aspart Pre-mixed vs Insulin Glargine Plus 1 Prandial Insulin Glulisine or Step wise Addition of Glulisine to Glargine in Type 2 Diabetes Uncontrolled with Oral Agents
    Polonsky, William H.
    Rosenstock, Julio
    Gilmore, Amanda S.
    Wei, Wenhui
    Chaudhari, Sham L.
    Riddle, Matthew C.
    [J]. DIABETES, 2011, 60 : A616 - A616
  • [43] Effectiveness and Safety of iGlarLixi (Insulin Glargine 100 U/mL Plus Lixisenatide) in Type 2 Diabetes According to the Timing of Daily Administration: Data from the REALI Pooled Analysis
    Haluzik, Martin
    Seufert, Jochen
    Guja, Cristian
    Bonnemaire, Mireille
    Bigot, Gregory
    Tournay, Mathilde
    Kis, Janos Tibor
    Freemantle, Nick
    [J]. DIABETES THERAPY, 2023, 14 (04) : 639 - 652
  • [44] Effectiveness and Safety of iGlarLixi (Insulin Glargine 100 U/mL Plus Lixisenatide) in Type 2 Diabetes According to the Timing of Daily Administration: Data from the REALI Pooled Analysis
    Martin Haluzík
    Jochen Seufert
    Cristian Guja
    Mireille Bonnemaire
    Gregory Bigot
    Mathilde Tournay
    János Tibor Kis
    Nick Freemantle
    [J]. Diabetes Therapy, 2023, 14 : 639 - 652
  • [45] Stepwise intensification of insulin therapy in Type2 diabetes managementexploring the concept of the basal-plus approach in clinical practice
    Owens, D. R.
    [J]. DIABETIC MEDICINE, 2013, 30 (03) : 276 - 288
  • [46] Comparison of a Multiple Daily Insulin Injection Regimen (Glargine or Detemir Once Daily Plus Prandial Insulin Aspart) and Continuous Subcutaneous Insulin Infusion (Aspart) in Short-Term Intensive Insulin Therapy for Poorly Controlled Type 2 Diabetes Patients
    Lv, Wen-shan
    Li, Li
    Wen, Jun-ping
    Pan, Rong-fang
    Sun, Rui-xia
    Wang, Jing
    Xian, Yu-xin
    Cao, Cai-xia
    Gao, Yan-yan
    [J]. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2013, 2013
  • [47] Efficacy and safety of switching to insulin icodec, a once-weekly basal insulin, vs insulin glargine U100 in patients with type 2 diabetes inadequately controlled on OADs and basal insulin
    Bajaj, H.
    Isendahl, J.
    Gowda, A.
    Stachlewska, K.
    Rosenstock, J.
    [J]. DIABETOLOGIA, 2020, 63 (SUPPL 1) : S317 - S317
  • [48] Once-weekly basal insulin icodec offers comparable efficacy and safety vs once-daily insulin glargine U100 in insulin naive patients with type 2 diabetes inadequately controlled on OADs
    Rosenstock, J.
    Kjaersgaard, M.
    Moller, D.
    Hansen, M.
    Goldenberg, R.
    [J]. DIABETOLOGIA, 2020, 63 (SUPPL 1) : S28 - S29
  • [49] Insulin lispro low mixture twice daily vs basal insulin glargine once daily and prandial insulin lispro once daily as insulin intensification strategies in patients with type 2 diabetes: Latin American subpopulation analysis of a randomized trial
    Rojas, Arturo
    Sposetti, Georgina
    Gross, Jorge L.
    Barbieri, Douglas Eugenio
    Duan, Ran
    Linetzky, Bruno
    De Lana, Janaina Martins
    Stempa, Oded
    Rodriguez, Angel
    [J]. DIABETOLOGY & METABOLIC SYNDROME, 2016, 8
  • [50] Insulin lispro low mixture twice daily vs basal insulin glargine once daily and prandial insulin lispro once daily as insulin intensification strategies in patients with type 2 diabetes: A Latin American subpopulation analysis of a randomized trial
    Douglas Eugenio Barbieri
    Ran Duan
    Jorge Gross
    Bruno Linetzky
    Janaina Martins De Lana
    Arturo Rojas
    Georgina Sposetti
    Oded Stempa
    Angel Rodriguez
    [J]. Diabetology & Metabolic Syndrome, 7 (Suppl 1):
12345